{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:50:58Z","timestamp":1788565858553,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","heartrhythmjournal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.hrthm.2019.01.028","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T11:42:01Z","timestamp":1548848521000},"page":"990-995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Safety of rapid switching from amiodarone to dofetilide in atrial fibrillation patients with an implantable cardioverter\u2013defibrillator"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5846-4578","authenticated-orcid":false,"given":"Sharan Prakash","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8183-8443","authenticated-orcid":false,"given":"Mohit","family":"Turagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donita","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Bommana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Jeffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheri","family":"Nydegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Gopinathannair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanunjaya","family":"Lakkireddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2019.01.028_bib1","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.01.028_bib2","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0735-1097(03)00332-2","article-title":"Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study","volume":"41","author":"Carlsson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.01.028_bib3","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jacc.2003.11.032","article-title":"The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation","volume":"43","author":"Olshansky","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.01.028_bib4","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.01.028_bib5","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.CIR.100.19.2025","article-title":"Evidence-based analysis of amiodarone efficacy and safety","volume":"100","author":"Connolly","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.01.028_bib6","doi-asserted-by":"crossref","first-page":"37R","DOI":"10.1016\/S0002-9149(99)00700-6","article-title":"Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations","volume":"84","author":"Pollak","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.01.028_bib7","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(97)05281-1","article-title":"Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2019.01.028_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.CCM.0000151048.72393.44","article-title":"Hepatotoxicity during rapid intravenous loading with amiodarone: description of three cases and review of the literature","volume":"33","author":"R\u00e4tz Bravo","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.hrthm.2019.01.028_bib9","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.01.028_bib10","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.CIR.102.19.2385","article-title":"Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial\u00a0fibrillation or atrial flutter: the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study","volume":"102","author":"Singh","year":"2000","journal-title":"Circulation"},{"issue":"17 Suppl","key":"10.1016\/j.hrthm.2019.01.028_bib11","first-page":"1633","article-title":"Conversion of atrial fibrillation and maintenance of sinus rhythm by dofetilide: the EMERALD (European and Australian Multicenter Evaluative Research on Atrial Fibrillation Dofetilide) study (abstract)","volume":"98","author":"Greenbaum","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.01.028_bib12","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(00)03402-4","article-title":"Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial","volume":"356","author":"K\u00f8ber","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2019.01.028_bib13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.01.028_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacep.2016.05.007","article-title":"Discontinuation of dofetilide from QT prolongation and ventricular tachycardia in the real world","volume":"2","author":"Anand","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.01.028_bib16","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1001\/archinte.160.12.1741","article-title":"Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology","volume":"160","author":"Goldschlager","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2019.01.028_bib18","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.hrthm.2014.08.026","article-title":"New formula for evaluation of the QT interval in patients with left bundle branch block","volume":"11","author":"Bogossian","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.01.028_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/pace.13027","article-title":"Applicability of a novel formula (Bogossian formula) for evaluation of the QT-interval in heart failure and left bundle branch block due to right ventricular pacing","volume":"40","author":"Frommeyer","year":"2017","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.01.028_bib20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/CIRCEP.114.002339","article-title":"Safety of oral dofetilide for rhythm control of atrial fibrillation and atrial flutter","volume":"8","author":"Abraham","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.01.028_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1542-474X.2007.00161.x","article-title":"Dofetilide-induced long QT and torsades de pointes","volume":"12","author":"Aktas","year":"2007","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hrthm.2019.01.028_bib22","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.amjcard.2007.04.020","article-title":"Risk factors and predictors of torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving dofetilide","volume":"100","author":"Pedersen","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.01.028_bib23","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.hrthm.2018.01.027","article-title":"Dofetilide dose reductions and discontinuations in women compared with men","volume":"15","author":"Pokorney","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.01.028_bib24","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0735-1097(01)01106-8","article-title":"Pause-dependent polymorphic ventricular tachycardia during long-term treatment with dofetilide: a placebo-controlled, implantable cardioverter-defibrillator-based evaluation","volume":"37","author":"Mazur","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.01.028_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/clc.22090","article-title":"Effects of dronedarone started rapidly after amiodarone discontinuation","volume":"36","author":"Immordino","year":"2013","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hrthm.2019.01.028_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijcard.2017.01.157","article-title":"Practice variation in the re-initiation of dofetilide: an observational study","volume":"236","author":"Turagam","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2019.01.028_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0008-6363(99)00232-1","article-title":"Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in\u00a0vivo: interactions with acute sotalol","volume":"44","author":"Merot","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2019.01.028_bib28","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1540-8167.1997.tb01018.x","article-title":"Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart","volume":"8","author":"Sicouri","year":"1997","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"Suppl","key":"10.1016\/j.hrthm.2019.01.028_bib29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0022-0736(98)80070-8","article-title":"Cellular basis for QT dispersion","volume":"30","author":"Antzelevitch","year":"1998","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.hrthm.2019.01.028_bib30","first-page":"173","article-title":"Managing atrial fibrillation in the global community: the European perspective","volume":"2013","author":"Kaba","year":"2013","journal-title":"Glob Cardiol Sci Pract"},{"key":"10.1016\/j.hrthm.2019.01.028_bib31","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/CIRCULATIONAHA.113.005451","article-title":"Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry","volume":"129","author":"Oldgren","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.01.028_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1476-5381.2009.00427.x","article-title":"Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development","volume":"159","author":"Salvi","year":"2010","journal-title":"Br J Pharmacol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527119301006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527119301006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T04:21:46Z","timestamp":1561695706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527119301006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1547527119301006"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2019.01.028","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of rapid switching from amiodarone to dofetilide in atrial fibrillation patients with an implantable cardioverter\u2013defibrillator","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2019.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}